Overall Status

Active, not recruiting (1)

Not yet recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 2 (2)

phase 3 (1)

Sponsor

Asan Medical Center (1)

European Organisation for Research and Treatment of Cancer - EORTC (1)

Peking University Cancer Hospital & Institute (1)

Collaborator

Cooperative Trials Group for Neuro-Oncology (COGNO) (1)

Intervention

camrelizumab (1)

radiotherapy (1)

surgery (1)

temcap (1)

temozolomide (1)

Study Documents

Intervention Type

drug (3)

procedure (1)

radiation (1)

Funder Type

Other (3)

Study Type

Interventional (3)

temozolomide

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Melanoma, Acral Melanoma, Temozolomide Trial (Camrelizumab)

Not yet recruiting

Melanoma
+6 more

Camrelizumab

(no location specified)

Aug 21, 2022

Low-grade Glioma, Temozolomide, Phase III Trial in Worldwide (drug, radiation, procedure)

Terminated

Low-grade Glioma
+3 more

Temozolomide
+2 more

Woolloongabba, Brisbane, QLD, Australia
+44 more

Jan 31, 2022

Neuroendocrine Tumors, Neuroendocrine Carcinoma, Temozolomide Trial in Seoul (TEMCAP)

Active, not recruiting

Neuroendocrine Tumors
+3 more

TEMCAP

Seoul, Korea, Republic of

Asan Medical Center, University of Ulsan College of Medicine

Dec 13, 2020